Back to Journals » Journal of Pain Research

SJR OA
CiteScore
Impact Factor

Journal of Pain Research

ISSN: 1178-7090


       

Editor-in-Chief: Dr Michael Schatman

An international, peer-reviewed, open access, online journal that welcomes laboratory and clinical findings in the fields of pain research and the prevention and management of pain. Original research, reviews, symposium reports, hypothesis formation and commentaries are all considered for publication.


This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

The Journal of Pain Research is affiliated with the American Society of Pain & Neuroscience. Learn more.
 

Articles:

Latest articles:

- 5 records -

Original Research
Opioids and Substance Abuse

A Single Center Exploratory Survey of Patients and Nurses on post-Surgical Oral Opioid Delivery Through Patient-Controlled Analgesia

Mirza DH, Zha L, See C, Paoletti IN, Dai F, Hocevar M, Li J, Wiznia D

Journal of Pain Research 2024, 17:2483-2494

Published Date: 26 July 2024

Original Research
Behavioral Approaches to Pain

Avoidance and Endurance Responses to Pain Before and with Advanced Chronification: Preliminary Results from a Questionnaire Survey in Adult Patients with Non-Cancer Pain Conditions

Teichmüller K, Kübler A, Rittner HL, Kindl GK

Journal of Pain Research 2024, 17:2473-2481

Published Date: 25 July 2024

Review
Integrative/Acupuncture

Acupoints for Headache with Blood Stasis Syndrome: a Literature Study Based on Data Mining Technology

Shi JY, Li TT, Yang HT, Zhang S, An R, Mao L, Li Y, Li Q, Luan GY, Shen Y, Wang EL, Liu GH

Journal of Pain Research 2024, 17:2455-2471

Published Date: 26 July 2024

Original Research
Pre-Clinical/Scientific

Rat Model of Neuropathic Pain Induced by Spinal Nerve Ligation: A New Approach via an Oblique Lateral Incision

Cheng Z, Feng S, Yang L, Huang J, Chen X, Guo Y, Xiang Y, Peng B

Journal of Pain Research 2024, 17:2443-2454

Published Date: 22 July 2024

Original Research
Headache and Facial Pain

Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial

Lipton RB, Thiry A, Morris BA, Croop R

Journal of Pain Research 2024, 17:2431-2441

Published Date: 22 July 2024


Read more articles